The Oil & Gas Journal, first published in 1902, is the world's most widely read petroleum industry publication. OGJ delivers international oil and gas industry news; analysis of issues and events; practical technology for design, operation, and maintenance of oil and gas operations; and important statistics on energy markets and industry activity.

OGJ is edited to meet the needs of engineers, geoscientists, managers, and executives throughout the oil and gas industry. It is part of Endeavor Business Media, Nashville, Tenn., which also publishes Offshore Magazine.

Endeavor Business Media’s Petroleum Group also produces targeted e-Newsletters; hosts global conferences and exhibitions, seminars, and forums; and publishes directories, technical books, print and electronic databases, surveys, and maps.

Additional Information

Website & Technical Help

For help with subscription purchases or refunds, or trouble logging into the paid subscription content on www.ogj.com, please contact Customer Service at [email protected] or call 1-847-559-7598.

For more customer service information, please click here.

hyperCORE International Welcomes New Vice President and Treasurer to Executive Leadership Team

Jeffrey Smyth of TrueBlue Clinical Research and Olivia McIver of Applied Research Center join hyperCORE's executive team, strengthening governance and supporting sustainable growth across its partner site networks.

LAKE MARY, FL, September 29, 2025 /24-7PressRelease/ -- hyperCORE International, a leading collaborative network of clinical trial sites across North America, is pleased to announce updates to its executive leadership team. Jeffrey Smyth, President and Executive Director of partner site network TrueBlue Clinical Research, has been appointed Vice President, and Olivia McIver, Director of Clinical Operations of partner site network Applied Research Center, was appointed Treasurer. These additions strengthen the organization's governance and ensure continued alignment with hyperCORE's mission of driving efficiency and excellence across its collective partner site networks. In their new roles, Smyth and McIver bring complementary expertise to support hyperCORE's growth, and will play a key role in overseeing financial stewardship and supporting long-term sustainability.

hyperCORE's partner site networks include AGA Clinical Trials; Alcanza Clinical Research; Apex Trials; Applied Research Center; Atlas Clinical Research; CaRe Clinics; Epic Medical Research; FOMAT Medical Research; TrueBlue Clinical Research; and QCR Network. Each independently operated network participates in harmonized operational frameworks that streamline study delivery at scale.

"hyperCORE's strength lies in its ability to unify best-in-class research sites through shared operational excellence," said Nicholas Focil, President of hyperCORE. "As we continue to grow, having a dedicated and strategic Vice President and integrated board Treasurer is essential to guide our leadership framework and maintain our strategic mobility across our industry. We're excited to welcome both Jeffrey and Olivia to the executive team."

Alongside these new appointments, Nicholas Focil, CEO of FOMAT Medical Research, will continue serving as President, and Mark Scullion, CEO of Atlas Clinical Research, will continue in his role as Secretary, providing trusted leadership to guide hyperCORE's next phase of growth.

hyperCORE International is a partner site network of leading clinical research site organizations. Boasting over 80 active trial sites across five countries and two continents, hyperCORE's partners have jointly completed 7,500+ studies involving over 150,000+ randomized participants. Each partner member operates independently but integrates harmonized operational frameworks to optimize efficiency, standardization, and excellence.

hyperCORE remains committed to advancing clinical research through safe, ethical, timely studies; efficient enrollment; and superior retention—empowered by its members' top-tier awards for performance, quality, and innovation.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.